Evidence map›Paper›PMID 35345853›Full record

ReviewFrontiers in cell and developmental biology2022

Aberrant SKP1 Expression: Diverse Mechanisms Impacting Genome and Chromosome Stability.

Laura L Thompson, Kailee A Rutherford, Chloe C Lepage, Kirk J McManus

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of LMO7 in cancer (Review).Oncology reports · 2024
    Review
  7. Article
  8. ReducedCells · 2022
    Article
  9. The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Laura L ThompsonCancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
Kailee A RutherfordCancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
Chloe C LepageCancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
Kirk J McManusCancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
University of Manitoba · CACancerCare Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The S-phase Kinase-Associated Protein 1 (SKP1) is a core component of the SKP1, Cullin 1, F-box protein (SCF) complex, an E3 ubiquitin ligase that serves to poly-ubiquitinate a vast array of protein targets as a signal for their proteasomal degradation, thereby playing a critical role in the regulation of downstream biological processes. Many of the proteins regulated by SKP1 and the SCF complex normally function within pathways that are essential for maintaining genome stability, including DNA damage repair, apoptotic signaling, and centrosome dynamics. Accordingly, aberrant SKP1 and SCF complex expression and function is expected to disrupt these essential pathways, which may have pathological implications in diseases like cancer. In this review, we summarize the central role SKP1 plays in regulating essential cellular processes; we describe functional models in which

Indexed as

cancercentrosome dynamicschromosome instabilityDNA damage responseFbox proteingenome instabilitySCF complexSKP1

Identifiers

PMID35345853
PMCPMC8957228
OpenAlexW4220825586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.